Showing 20 of 88 recruiting trials for “giant-cell-glioblastoma”
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
RecruitingNCT07411690 ↗
Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
👨⚕️ Michal Senger, M.D., Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland📍 1 site📅 Started Feb 2026View details ↗
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
5G-PEARL: Paxalisib in Malignant Brain Tumours
👨⚕️ Juanita Lopez, MD, PhD, National Health Service, United Kingdom📍 1 site📅 Started Jan 2026View details ↗
OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients
Enrolling by InvitationNCT07417774 ↗
Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
👨⚕️ David Peereboom, MD, Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute📍 1 site📅 Started Aug 2025View details ↗
PH Sensitive MRI Based Resections of Glioblastoma
CUE-102 in Recurrent Glioblastoma
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
👨⚕️ Phioanh Nghiemphu, MD, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Jul 2025View details ↗
Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy
The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
G-CSF After Chemo-radiation in Patients With Glioblastoma
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Apr 2025View details ↗
Allogeneic γδT Cells in Glioblastoma
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →